US$ 24.84
glp-1 receptor agonist type 1 diabetes trial liraglutide Oral GLP-1-Based Therapeutics in the Obesity–Metabolic Syndrome–Diabetes Continuum: Translational Advances, Clinical Barriers, and Emerging Strategies Liraglutide vs Semaglutide GLP-1 vs
Description
This dual benefit of appetite control and blood sugar regulation is one reason why GLP-1 agonists are considered a promising treatment for both obesity and type 2 diabetes

In the brain, the two incretins are not redundant and may complement each other in regulating orexigenic and anorexigenic pathways (148)

doi: 10.1016/j.ejphar.2021.174310 [DOI] [PubMed] [Google Scholar] 47

It helps regulate blood sugar, slows stomach emptying and contributes to feelings of fullness

This has increased the possibility of hypothalamic leptin resistance in IIH
